Bayer Keeps Ban On Generic Xarelto Sales Alive In Denmark
Denmark's Supreme Court has upheld an injunction stopping three of Bayer's three rivals selling generic versions of Xarelto, straying from recent decisions invalidating the patent in the U.K. and Germany....To view the full article, register now.
Already a subscriber? Click here to view full article